A pilot study of Cutimed<sup>®</sup> Sorbact<sup>®</sup> versus ACTICOAT™ versus Silverlon<sup>®</sup> for the treatment of burn wounds in a South African adult burn unit

  • Wayne George Kleintjes Medi-Clinic Louis Leipoldt
  • D Schoeman Medi-Clinic Louis Leipoldt
  • L Collier Medi-Clinic Louis Leipoldt
Keywords: Cutimed® Sorbact®, ACTICOAT™, Silverlon®, pilot study, burn wounds

Abstract

Background: Since significant clinical data are unavailable on the use of Cutimed® Sorbact® in burns, a decision was taken to test it against the best anti-infective dressings used in our burns unit. Method: A random prospective study was conducted in which Cutimed® Sorbact® was compared with control products, ACTICOAT™ and Silverlon®. Selected patients had partial- or full-thickness burns. Results: Thirteen patients were included in the pilot study. Fifty-seven dressing areas were tested. A statistical difference between the tested product and the control products was not found through either clinical observation or microbiological analysis. Conclusion: This pilot study confirmed that the Cutimed® Sorbact® dressing was safe when treating burn wounds over a three-day period. In addition, the potential to use it on earlier or fresher burn wounds warrants the further study of Cutimed® Sorbact® as a potential skin substitute.

Author Biographies

Wayne George Kleintjes, Medi-Clinic Louis Leipoldt
MBChB, MMed(Plast), FC(Plast Surg)SA, PhD Head of Adult Burns Unit Emergency Medicine Registrar Houseman Mediclinic Louis Leipoldt
D Schoeman, Medi-Clinic Louis Leipoldt
MBChB
L Collier, Medi-Clinic Louis Leipoldt
MBChB
Published
2015-09-28
Section
General Review